en

PRODUCT DETAIL

Kisunla 350 mg koncentrát na infúzny roztok

Code 1352F
MA number EU/1/25/1926/001
Product Form: con inf 1x20 ml/350 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Eli Lilly Nederland B.V., Netherland
Therapeutic Class: 87 - VARIA I
ATC:
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06D ANTI-DEMENTIA DRUGS
N06DX Other anti-dementia drugs
N06DX05 Donanemab
Shelf life: 24
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 24.09.2025
Validity: 24.09.2030
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 09.10.2025
eu-flag.png sk-flag.png